The Trend in Age-Adjusted Incidence of Head and Neck Cancer in South Korea over the Past 20 Years.

IF 2.9 3区医学 Q1 OTORHINOLARYNGOLOGY

Clinical and Experimental Otorhinolaryngology Pub Date : 2025-01-24 DOI:10.21053/ceo.2024.00346

Jae Hoon Cho, Jeffrey D Suh, Young Chang Lim

{"title":"The Trend in Age-Adjusted Incidence of Head and Neck Cancer in South Korea over the Past 20 Years.","authors":"Jae Hoon Cho, Jeffrey D Suh, Young Chang Lim","doi":"10.21053/ceo.2024.00346","DOIUrl":null,"url":null,"abstract":"Objectives: We aimed to calculate the age-adjusted incidence rate of head and neck cancer (HNC) in South Korea from 1999 to 2020 and investigate the incidence trend of HNC excluding the effect of population aging.Methods: Data were obtained from the Cancer Registration Statistics Program. All 12 types of HNCs were analyzed. For each HNC type, the crude incidence rate and number of new cases during 1999-2020 are presented according to sex and age group. Age-adjusted incidence rates were calculated based on the World Standard Population (WHO 2000-2025), and its trends were also measured.Results: Although the crude incidence rates of all HNCs have been steadily increasing from 1999 to 2020, the absolute values were very low in most cases, less than 2/100,000. The male-to-female ratio was 1 or higher for all HNCs except thyroid cancer, and 10 or higher for laryngeal cancer and hypopharyngeal cancer. The trend of age-adjusted incidence was a gradual increase for tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer, a decrease for laryngeal cancer, and no significant change for the remaining HNCs.Conclusion: Excluding the population aging effect, tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer among HNCs have been increasing in South Korea over the past 20 years, while laryngeal cancer has been decreasing.","PeriodicalId":10318,"journal":{"name":"Clinical and Experimental Otorhinolaryngology","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21053/ceo.2024.00346","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: We aimed to calculate the age-adjusted incidence rate of head and neck cancer (HNC) in South Korea from 1999 to 2020 and investigate the incidence trend of HNC excluding the effect of population aging.

Methods: Data were obtained from the Cancer Registration Statistics Program. All 12 types of HNCs were analyzed. For each HNC type, the crude incidence rate and number of new cases during 1999-2020 are presented according to sex and age group. Age-adjusted incidence rates were calculated based on the World Standard Population (WHO 2000-2025), and its trends were also measured.

Results: Although the crude incidence rates of all HNCs have been steadily increasing from 1999 to 2020, the absolute values were very low in most cases, less than 2/100,000. The male-to-female ratio was 1 or higher for all HNCs except thyroid cancer, and 10 or higher for laryngeal cancer and hypopharyngeal cancer. The trend of age-adjusted incidence was a gradual increase for tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer, a decrease for laryngeal cancer, and no significant change for the remaining HNCs.

Conclusion: Excluding the population aging effect, tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer among HNCs have been increasing in South Korea over the past 20 years, while laryngeal cancer has been decreasing.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Otorhinolaryngology 医学-耳鼻喉科学

CiteScore

4.90

自引率

6.70%

发文量

审稿时长

6-12 weeks

期刊介绍： Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery. CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field. The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.